Yale’s clinical practice welcomes talented new physicians
New group brings expertise in fields from pediatrics to pathology
John Roberts, MD, is the new director of the Adult Sickle Cell Program at Smilow Cancer Hospital at Yale-New Haven. He will also care for patients in Yale Cancer Center’s Prostate and Urologic Cancers Program. Dr. Roberts is board-certified in internal medicine and medical oncology, and has clinical and research interests in sickle cell disease, urological malignancies and developmental therapeutics/clinical trials. He joins the practice from Virginia Commonwealth University (VCU), where he was past interim chair of the division of hematology, oncology and palliative care, and past co-director of the VCU Adult Sickle Cell Program. At VCU’s Massey Cancer Center, he was associate director for clinical research and director of the clinical protocol and data management shared resource. He completed his medical degree at the University of Pennsylvania.
Matthew Grant, MD, is an assistant professor in infectious diseases. He holds board certifications in internal medicine and infectious diseases. He has clinical interests in systemic fungal infections and transplantation medicine. Dr. Grant completed his medical degree at SUNY Upstate Medical University, his residency in internal medicine at Thomas Jefferson University and his fellowship in infectious diseases at Temple University Hospital.
Lenore Buckley, MD, MPH, is a professor who is board-certified in internal medicine, pediatrics, rheumatology and pediatric rheumatology. Her clinical interests include adult and pediatric lupus, glucocorticoid-induced osteoporosis and rheumatoid arthritis. Dr. Buckley completed her medical degree at the University of Rochester, her residency in internal medicine/pediatrics at North Carolina Memorial Hospital, a fellowship in rheumatology at University of Vermont College of Medicine and her master’s degree in public health at Harvard School of Public Health.
Medical Oncology/Yale Cancer Center
Breast Cancer Program
Lajos Pusztai, MD, DPhil, will lead the breast cancer medical oncology team at Smilow Cancer Hospital at Yale-New Haven and co-direct the Cancer Genetics Research Program. Dr. Pusztai is board-certified in medical oncology, and has clinical interests in breast cancer and cancer genetics. His research focuses on the developing pharmacogenomic markers of response to breast cancer therapy and identifying methods to select the optimal treatment for each patient. His goal is to discover the next generation of tamoxifen- and trastuzumab-like drugs through the identification of critical drug targets in human breast cancer. He completed his medical degree at the Semmelweis University School of Medicine in Budapest, Hungary, and his doctorate of philosophy at the University of Oxford. He completed an internship and a residency at University of Rochester St. Mary’s Hospital, and a medical oncology fellowship at University of Texas Anderson Cancer Center.
Jennifer M. Kapo, MD, an associate professor of medicine in geriatrics, is the new chief of palliative medicine for Yale Cancer Center and Smilow Cancer Hospital at Yale-New Haven. Dr. Kapo joins Yale from the University of Pennsylvania, where she was medical director of palliative care services for the Philadelphia Veteran’s Administration Medical Center. Dr. Kapo holds board certifications in internal medicine, geriatric medicine, and hospice and palliative medicine. She completed her medical degree at University of Pennsylvania Medical School. In addition to her clinical work at Yale, she is developing a research mission in palliative medicine and creating an ACGME-certified fellowship in hospice and palliative care.
Rafeed Alkawadri, MD, is an instructor who is board-certified in neurology and has a clinical interest in epilepsy. Dr. Alkawadri completed his medical degree at the University of Damascus, and his internal medical internship and neurology residency at the University of Texas SW Medical Center. He comes to Yale after completing a fellowship in neurophysiology/epilepsy at the Cleveland Clinic Foundation.
Emily J. Gilmore, MD, is an assistant professor of neurology and staff neurointensivist in the neuroscience intensive care unit. Her clinical interests in neurocritical care include acute stroke, status epilepticus, subarachnoid hemorrhage and traumatic brain injury. She completed her medical degree at the University of New Mexico in Albuquerque and her residency at Columbia's Neurological Institute of New York, where she was chief resident and a fellow in neurophysiology and neurocritical care.
David Y. Hwang, MD, is an assistant professor of neurology and staff neurointensivist in the neuroscience intensive care unit at Yale-New Haven Hospital. Board-certified in neurology, he has clinical and research interests in optimizing decision-making by families of patients in intensive care units, improving the long-term outcomes of intensive care unit patients, integrating end-of-life care in intensive care units, and managing acute stroke. Dr. Hwang completed his medical degree at Harvard Medical School. Before coming to Yale, he was a clinical and research fellow in neurocritical care at Massachusetts General Hospital/Brigham and Women’s Hospital, where he completed his residency and served as chief resident in neurology.
Samuel Katz, MD, PhD, is an assistant professor of pathology who is board-certified in both anatomic and hematological pathology. His clinical interests are in lymphomas and leukemias, and his research interests are in BCL-2 protein family regulation of apoptosis. He is returning to Yale, where he was an undergraduate, having completed his medical degree and PhD at Harvard Medical School, followed by a residency in pathology and fellowship in hematopathology at Brigham & Women’s Hospital.
Deniz Engin, MD, is an instructor in pediatrics specializing in pediatric critical care medicine. He is board-certified in pediatrics and board-eligible in pediatric critical care. Dr. Engin completed his medical degree in University of Istanbul in Turkey, and pediatric residencies at Long Island College Hospital Beth Israel Medical Center and Cohen Children’s Medical Center of New York. He was a fellow in pediatric critical care medicine at Yale School of Medicine.
Paul Landry Aronson, MD, is an assistant professor of pediatrics in pediatric emergency medicine. He is the director of the pediatric emergency medicine sub-internship and has clinical and research interests in the febrile young infant, herpes simplex virus, and family-centered care. His main academic interest is medical education. He completed his medical degree at New York University School of Medicine, and was a resident and chief resident at The Children’s Hospital of Philadelphia, where he also completed his fellowship in pediatric emergency medicine.
Jaspreet Loyal, MD, MS, joins the faculty as assistant professor of general pediatrics and director of the well newborn nursery. She has clinical interests in pediatric primary care, medical education and global health. Dr. Loyal holds a master’s degree in epidemiology from Stanford University, completed her medical degree at the Medical College Wisconsin, and was a pediatric resident and chief resident at New York Presbyterian Weill Cornell Medical Center.
Hulda Einarsdottir, MD, is a board-certified surgeon who joins gastrointestinal/colon and rectal surgery. She has clinical interests in cancer of the colon, rectum and anus; inflammatory bowel disease; Crohn’s disease and ulcerative colitis; pelvic floor disorders; fecal incontinence; anal sphincter injury; rectal prolapse; rectocele; benign anorectal disorders; and laparoscopic and reconstructive surgery. Dr. Einarsdottir completed her medical degree at the University of Iceland, her surgical residency at Yale School of Medicine, and a fellowship in colon and rectal surgery at Ochsner Clinic Foundation.
Theodore Tsangaris, MD, is an associate professor of surgery and a board-certified surgeon joining surgical oncology. He spent the last 10 years as director of the Johns Hopkins/Avon Breast Center. He has clinical interests in breast cancer and nipple-sparing mastectomy, and research interests in breast cancer prevention, identification of tumor markers and sentinel lymph node dissection, as well as other surgical procedures in the treatment of breast cancer. He completed his medical degree, general surgery internship and residency at George Washington University School of Medicine, and was a breast surgical oncology fellow at Baylor University Medical Center. In New Haven, he will assume the role of director of Outpatient Breast Services for the Smilow Cancer Hospital Network and help with future endeavors with other campuses as Smilow develops a more prominent footprint in the state. Dr. Tsangaris is also a commander in the United States Navy Reserve.
Trauma, Surgical Critical Care and Surgical Emergencies
Bishwajit Bhattacharya, MD,an assistant professor, is a board-certified surgeon and board-eligible surgical critical care specialist. He completed his medical degree at SUNY Upstate Medical Center and his general surgery residency at New York Medical College. He was a fellow in surgical critical care at Yale-New Haven Hospital.
Ranjit Bindra, MD, PhD, an assistant professor of therapeutic radiology, is a board-eligible radiation oncologist with clinical interests in pediatrics and the central nervous system. His laboratory is focused on developing novel therapeutics that can be used concurrently with radiation therapy and chemotherapy for the treatment of both adult and pediatric brain tumors. Dr. Bindra completed his medical degree at Yale School of Medicine, his PhD at Yale University Graduate School and his residency at Memorial Sloane-Kettering Cancer Center.
James Hansen, MD, is an assistant professor of therapeutic radiology who is board-eligible in radiation oncology. Dr. Hansen completed his medical degree at the UCLA School of Medicine, was a postdoctoral scholar in the UCLA Department of Medicine San Fernando Valley Program, and completed a residency and chief residency in therapeutic radiology at Yale School of Medicine. He is a physician-scientist, and his laboratory focuses on exploring the potential therapeutic applications of cell-penetrating lupus autoantibodies in cancer therapy.
Zain Husain, MD, is an assistant professor of therapeutic radiology who is board-eligible in radiation oncology. Dr. Husain has clinical interests in head and neck cancer, and lung cancer, as well as the use of stereotactic body radiation therapy for lung and spine tumors. He completed his medical degree at University of California Irvine School of Medicine, and a residency in therapeutic radiology at the University of Maryland, Radiation Oncology.